Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain
Open accessPublished version of a preprint
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Psilocybin, a naturally occurring, tryptamine alkaloid prodrug, is currently being investigated for the treatment of a range of psychiatric disorders. Preclinical reports suggest that the biological effects of psilocybin-containing mushroom extract or “full spectrum” (psychedelic) mushroom extract (PME), may differ from those of chemically synthesized psilocybin (PSIL). We compared the effects of PME to those of PSIL on the head twitch response (HTR), neuroplasticity-related synaptic proteins and frontal cortex metabolomic profiles in male C57Bl/6j mice. HTR measurement showed similar effects of PSIL and PME over 20 min. Brain specimens (frontal cortex, hippocampus, amygdala, striatum) were assayed for the synaptic proteins, GAP43, PSD95, synaptophysin and SV2A, using western blots. These proteins may serve as indicators of synaptic plasticity. Three days after treatment, there was minimal increase in synaptic proteins. After 11 days, PSIL and PME significantly increased GAP43 in the frontal cortex ( p = 0.019; p = 0.039 respectively) and hippocampus ( p = 0.015; p = 0.027) and synaptophysin in the hippocampus ( p = 0.041; p = 0.05) and amygdala ( p = 0.035; p = 0.004). PSIL increased SV2A in the amygdala ( p = 0.036) and PME did so in the hippocampus ( p = 0.014). In the striatum, synaptophysin was increased by PME only ( p = 0.023). There were no significant effects of PSIL or PME on PSD95 in any brain area when these were analyzed separately. Nested analysis of variance (ANOVA) showed a significant increase in each of the 4 proteins over all brain areas for PME versus vehicle control, while significant PSIL effects were observed only in the hippocampus and amygdala and were limited to PSD95 and SV2A. Metabolomic analyses of the pre-frontal cortex were performed by untargeted polar metabolomics utilizing capillary electrophoresis – Fourier transform mass spectrometry (CE-FTMS) and showed a differential metabolic separation between PME and vehicle groups. The purines guanosine, hypoxanthine and inosine, associated with oxidative stress and energy production pathways, showed a progressive decline from VEH to PSIL to PME. In conclusion, our synaptic protein findings suggest that PME has a more potent and prolonged effect on synaptic plasticity than PSIL. Our metabolomics data support a gradient of effects from inert vehicle via chemical psilocybin to PME further supporting differential effects. Further studies are needed to confirm and extend these findings and to identify the molecules that may be responsible for the enhanced effects of PME as compared to psilocybin alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Proceedings of the National Academy of Sciences
Richards, J. W. (1915) · Science · doi:10.1126/science.42.1074.161 · Cited by 13,983
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05672-9 · Cited by 817
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Shao, L.-X., Liao, C., Gregg, I., Davoudian, P. A., Savalia, N. K., Delagarza, K., & Kwan, A. C. (2021) · doi:10.1101/2021.02.17.431629 · Cited by 628
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Shao, L.-X., Liao, C., Gregg, I., Davoudian, P. A., Savalia, N. K., Delagarza, K., & Kwan, A. C. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.008 · Cited by 626
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01316-5 · Cited by 478
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron, L. P., Tombari, R. J., Lu, J., Pell, A. J., Hurley, Z. Q., Ehinger, Y., Vargas, M. V., McCarroll, M. N., Taylor, J. C., Myers-Turnbull, D., et al. (2021) · Nature · doi:10.1038/s41586-020-3008-z · Cited by 473
Ruiz-Perez, D., Guan, H., Madhivanan, P., Mathee, K., & Narasimhan, G. (2020) · BMC Bioinformatics · doi:10.1186/s12859-019-3310-7 · Cited by 426
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
Janz, R., Goda, Y., Geppert, M., Missler, M., & Südhof, T. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)81046-6 · Cited by 367
PSD95: A synaptic protein implicated in schizophrenia or autism?
Coley, A. A., & Gao, W.-J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.016 · Cited by 359
Synaptophysin: leading actor or walk‐on role in synaptic vesicle exocytosis?
Valtorta, F., Pennuto, M., Bonanomi, D., & Benfenati, F. (2004) · BioEssays · doi:10.1002/bies.20012 · Cited by 345
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
Structure-based discovery of nonhallucinogenic psychedelic analogs
Cao, D., Yu, J., Wang, H., Luo, Z., Liu, X., He, L., Qi, J., Fan, L., Tang, L., Chen, Z., et al. (2022) · Science · doi:10.1126/science.abl8615 · Cited by 312 · cited 1×
“This therapeutic mechanism has received considerable emphasis in the development of novel, non-hallucinogenic, psychedelic agents [25 – 27].”
Chen, X., Levy, J. M., Hou, A., Winters, C., Azzam, R., Sousa, A. A., Leapman, R. D., Nicoll, R. A., & Reese, T. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517045112 · Cited by 310
Schiff, P. L. (2006) · American Journal of Pharmaceutical Education · doi:10.1016/s0002-9459(24)07817-3 · Cited by 291 · cited 1×
“LSD was originally synthesized from lysergic acid which is derived from ergotamine, an alkaloid found in the wheat-infecting ergot fungus [6].”
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation
Fernández, C. O., Hoyer, W., Zweckstetter, M., Jares‐Erijman, E. A., Subramaniam, V., Griesinger, C., & Jovin, T. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600211 · Cited by 255
Synaptic Changes in Alzheimer's Disease
Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., & Cole, G. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63436-0 · Cited by 253
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity
Kaplan, A. L., Confair, D. N., Kim, K., Barros-Álvarez, X., Rodriguiz, R. M., Yang, Y., Kweon, O. S., Che, T., McCorvy, J. D., Kamber, D. N., et al. (2022) · Nature · doi:10.1038/s41586-022-05258-z · Cited by 245
Maricich, S. M., & Herrup, K. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19991105)41:2<281::aid-neu10>3.0.co;2-5 · Cited by 238
Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x17666190903103923 · Cited by 227 · cited 1×
“In regard to cannabis, it is recognized that not only cannabidiol, but a number of other “ entourage ” molecules exert signi fi cant biological effects along with those of delta-9-tetrahydrocanabinol ( Δ -9 THC) and modify the effect of Δ − 9 THC [7].”
Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling
Jones, K. A., Srivastava, D. P., Allen, J. A., Strachan, R. T., Roth, B. L., & Penzes, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905884106 · Cited by 226
de la Fuente Revenga, M., Zhu, B., Guevara, C. A., Naler, L. B., Saunders, J. M., Zhou, Z., Toneatti, R., Sierra, S., Wolstenholme, J. T., Beardsley, P. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109836 · Cited by 224
SV2 modulates the size of the readily releasable pool of secretory vesicles
Xu, T., & Bajjalieh, S. M. (2001) · Nature Cell Biology · doi:10.1038/35087000 · Cited by 212
He, Q., Dent, E. W., & Meiri, K. F. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03515.1997 · Cited by 211
Polyamines: Functions, Metabolism, and Role in Human Disease Management
Sagar, N. A., Tarafdar, S., Agarwal, S., Tarafdar, A., & Sharma, S. (2021) · Medical Sciences · doi:10.3390/medsci9020044 · Cited by 201
Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice
Xu, T.-T., Li, H., Dai, Z., Lau, G. K., Li, B.-Y., Zhu, W.-L., Liu, X.-Q., Liu, H.-F., Cai, W.-W., Huang, S.-Q., et al. (2020) · Aging · doi:10.18632/aging.103035 · Cited by 200
Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020835 · Cited by 200
Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M. (2020) · doi:10.20944/preprints202011.0742.v1 · Cited by 200
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., Kuchař, M., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05236-w · Cited by 197
The promises and perils of psychedelic pharmacology for psychiatry
McClure-Begley, T. D., & Roth, B. L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00421-7 · Cited by 194
The developmental stages of synaptic plasticity
Lohmann, C., & Kessels, H. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2012.235119 · Cited by 180
Barker, S. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00536 · Cited by 177 · cited 1×
“Dimethyltryptamine (DMT) is of plant and animal origin and has also been identi fi ed in humans [3].”
Basics of mass spectrometry based metabolomics
Courant, F., Antignac, J., Dervilly, G., & Bizec, B. L. (2014) · PROTEOMICS · doi:10.1002/pmic.201400255 · Cited by 147 · cited 1×
“Metabolomics is an emerging fi eld that seeks to systematically characterize the unique chemical fi ngerprint that low-molecular-weight molecules leave behind after a given stimulus in a biological specimen [31].”
Jefsen, O. H., Elfving, B., Wegener, G., & Müller, H. K. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959614 · Cited by 127
Alder, J., Kanki, H., Valtorta, F., Greengard, P., & Poo, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00511.1995 · Cited by 121
Newly produced synaptic vesicle proteins are preferentially used in synaptic transmission
Truckenbrodt, S., Viplav, A., Jähne, S., Vogts, A., Denker, A., Wildhagen, H., Fornasiero, E. F., & Rizzoli, S. O. (2018) · The EMBO Journal · doi:10.15252/embj.201798044 · Cited by 119 · cited 1×
“Synaptic proteins are also involved in synaptic transmission and in maintaining synaptic structure and stability [30].”
Puzzling Out Synaptic Vesicle 2 Family Members Functions
Bartholome, O., Van den Ackerveken, P., Sánchez Gil, J., de la Brassinne Bonardeaux, O., Leprince, P., Franzen, R., & Rogister, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00148 · Cited by 107
Dinis-Oliveira, R. J., Pereira, C. L., & da Silva, D. D. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467211666181010154139 · Cited by 100 · cited 1×
“5-methoxy-dimethyltryptamine (5-MeO-DMT) is derived from the incilius alvarius species of toad [4] and the most common source of mescaline is the peyote cactus [5].”
DoseCal: a virtual calculator for dosage conversion between human and different animal species
Janhavi, P., Divyashree, S., Sanjailal, K. P., & Peddha, M. S. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1687523 · Cited by 100 · cited 1×
“…that we used (4.4 mg/kg) was chosen on the basis of our previous dose response study on the effect of psilocybin on the head twitch response [28], and in view of the fact this dose is equivalent in mice to a 25 mg dose in humans according to the widely used DoseCal dose conversion methodology [34].”
InfluentialNardai, S., László, M., Szabó, A., Alpár, A., Hanics, J., Zahola, P., Merkely, B., Frecska, E., & Nagy, Z. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113245 · Cited by 94
Van Court, R. C., Wiseman, M. S., Meyer, K. W., Ballhorn, D. J., Amses, K. R., Slot, J. C., Dentinger, B. T. M., Garibay-Orijel, R., & Uehling, J. K. (2022) · Fungal Biology · doi:10.1016/j.funbio.2022.01.003 · Cited by 94
Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity
Du, Y., Li, Y., Zhao, X., Yao, Y., Wang, B., Zhang, L., & Wang, G. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002647 · Cited by 94
Kozłowska, U., Nichols, C. D., Wiatr, K., & Figiel, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15509 · Cited by 89
Glatfelter, G. C., Pottie, E., Partilla, J. S., Sherwood, A. M., Kaylo, K., Pham, D. N. K., Naeem, M., Sammeta, V. R., DeBoer, S., Golen, J. A., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00177 · Cited by 89 · cited 1×
“Glatfelter et al. [19] recently showed that only the tertiary amines, psilocybin, psilocin, and 4-acetoxy-N,N-dimethyltryptamine (psilacetin) induced HTR in mice while secondary amines such as baeocystin and norpsilocin and quaternary ammonium compounds such as aeruginascin had little or no effect.”
Mandal, P. K., Gaur, S., Roy, R. G., Samkaria, A., Ingole, R., & Goel, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00420 · Cited by 88
Baeocystin and Norbaeocystin: New Analogs of Psilocybin from Psilocybe baeocystis
Leung, A. Y., & Paul, A. G. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600571007 · Cited by 85
Psychedelics and Neural Plasticity: Therapeutic Implications
Grieco, S. F., Castrén, E., Knudsen, G. M., Kwan, A. C., Olson, D. E., Zuo, Y., Holmes, T. C., & Xu, X. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1121-22.2022 · Cited by 82
Sherwood, A. M., Halberstadt, A. L., Klein, A. K., McCorvy, J. D., Kaylo, K. W., Kargbo, R. B., & Meisenheimer, P. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01061 · Cited by 79 · cited 1×
“In particular, it has been speculated that baeocystin or norpsilocin could potentially contribute to variable subjective effects [20].”
Snipes, G. J., Chan, S. Y., McGuire, C. B., Costello, B., Norden, J. J., Freeman, J., & Routtenberg, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-12-04066.1987 · Cited by 76
Ca2+-dependent Formation of a Dynamin-Synaptophysin Complex
Daly, C., & Ziff, E. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110815200 · Cited by 75
Blei, F., Dörner, S., Fricke, J., Baldeweg, F., Trottmann, F., Komor, A., Meyer, F., Hertweck, C., & Hoffmeister, D. (2020) · Chemistry – A European Journal · doi:10.1002/chem.201904363 · Cited by 75 · cited 1×
“…tryptamines, such as 4-phosphoryloxy-N-methyltryptamine (baeocystin), 4-phosphory-loxy-N,N,N-trimethyltryptamine (aeruginascin), 4-hydroxy-N-methyltryptamine (norpsilocin) and 4-phosphoryloxytryptamine (norbaeocystin) as well as β -carbolines such as harmine and harmaline, and terpenes [14 – 18].”
Effects of Psilocybe argentipes on Marble-Burying Behavior in Mice
MATSUSHIMA, Y., SHIROTA, O., KIKURA-HANAJIRI, R., GODA, Y., & EGUCHI, F. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90095 · Cited by 71
Sustained Activation of Postsynaptic 5-HT2A Receptors Gates Plasticity at Prefrontal Cortex Synapses
Berthoux, C., Barre, A., Bockaert, J., Marin, P., & Bécamel, C. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhy064 · Cited by 70
Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M. L., & Eloff, J. N. (2020) · Plants · doi:10.3390/plants9091127 · Cited by 68
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
Martin, D. A., Marona-Lewicka, D., Nichols, D. E., & Nichols, C. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.013 · Cited by 67
Gotvaldová, K., Hájková, K., Borovička, J., Jurok, R., Cihlářová, P., & Kuchař, M. (2021) · Drug Testing and Analysis · doi:10.1002/dta.2950 · Cited by 67
Shahar, O., Botvinnik, A., Esh-Zuntz, N., Brownstien, M., Wolf, R., Lotan, A., Wolf, G., Lerer, B., & Lifschytz, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214148 · Cited by 65 · cited 5×
“2 – 5) in 4 brain areas (frontal cortex, hippocampus, amygdala and striatum) 11 days after intraperitoneal injection of PSIL and PME, both at 4.4 mg/kg psilocybin.”
InfluentialSelf-citationZhuk, O., Jasicka-Misiak, I., Poliwoda, A., Kazakova, A., Godovan, V., Halama, M., & Wieczorek, P. (2015) · Toxins · doi:10.3390/toxins7041018 · Cited by 62
Molecular insights into psychedelic drug action
Slocum, S. T., DiBerto, J. F., & Roth, B. L. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15540 · Cited by 62
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Pic-Taylor, A., Mortari, M. R., & Caldas, E. D. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00547-w · Cited by 58
Cantallops, I., & Routtenberg, A. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19991105)41:2<208::aid-neu4>3.0.co;2-v · Cited by 58
Identification of ω-N-Methyl-4-hydroxytryptamine (Norpsilocin) as a Psilocybe Natural Product
Lenz, C., Wick, J., & Hoffmeister, D. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00407 · Cited by 57
Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids
Gotvaldová, K., Borovička, J., Hájková, K., Cihlářová, P., Rockefeller, A., & Kuchař, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214068 · Cited by 53
Zanikov, T., Gerasymchuk, M., Gojani, E. G., Robinson, G. I., Asghari, S., Groves, A., Haselhorst, L., Nandakumar, S., Stahl, C., Cameron, M., et al. (2023) · Molecules · doi:10.3390/molecules28062624 · Cited by 45
Interaction of Synaptophysin with the AP-1 Adaptor Protein γ-Adaptin
Horikawa, H., Kneussel, M., Far, O. E., & Betz, H. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1191 · Cited by 44
Console‐Bram, L., Fitzpatrick‐McElligott, S., & McElligott, J. G. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00079-x · Cited by 41
Genetic Survey of Psilocybe Natural Products
Dörner, S., Rogge, K., Fricke, J., Schäfer, T., Wurlitzer, J. M., Gressler, M., Pham, D. N. K., Manke, D. R., Chadeayne, A. R., & Hoffmeister, D. (2022) · ChemBioChem · doi:10.1002/cbic.202200249 · Cited by 39 · cited 2×
“…tryptamines, such as 4-phosphoryloxy-N-methyltryptamine (baeocystin), 4-phosphory-loxy-N,N,N-trimethyltryptamine (aeruginascin), 4-hydroxy-N-methyltryptamine (norpsilocin) and 4-phosphoryloxytryptamine (norbaeocystin) as well as β -carbolines such as harmine and harmaline, and terpenes [14 – 18].”
InfluentialAyahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice
Almeida, C. A. D. F., Pereira-Júnior, A. A., Rangel, J. G., Pereira, B. P., Costa, K. C. M., Bruno, V., Silveira, G. D. O., Ceron, C. S., Yonamine, M., Camarini, R., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113546 · Cited by 38
Doré, K., & Malinow, R. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.020 · Cited by 37
Synaptic Vesicle-bound Pyruvate Kinase can Support Vesicular Glutamate Uptake
Ishida, A., Noda, Y., & Ueda, T. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9833-3 · Cited by 36
Strauss, D., Ghosh, S. B., Murray, Z., & Gryzenhout, M. (2022) · Frontiers in Forests and Global Change · doi:10.3389/ffgc.2022.813998 · Cited by 33 · cited 7×
“We found that PSIL and PME signi fi cantly increased GAP43 levels in the frontal cortex (PSIL p = 0.019; PME p = 0.039) and hippocampus (PSIL p = 0.015; PME p = 0.027) and synaptophysin levels in the hippocampus (PSIL, p = 0.041; PME, p = 0.05) and amygdala (PSIL, p = 0.035; PME, p = 0.004).”
InfluentialExpression and secretion of synaptic proteins during stem cell differentiation to cortical neurons
Nazir, F. H., Becker, B., Brinkmalm, A., Höglund, K., Sandelius, Å., Bergström, P., Şatır, T. M., Öhrfelt, A., Blennow, K., Agholme, L., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.014 · Cited by 31
Revenga, M. D. L. F., Vohra, H., & González‐Maeso, J. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108595 · Cited by 31
Serotonergic Psychedelics in Neural Plasticity
Lukasiewicz, K., Baker, J. J., Zuo, Y., & Lu, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.748359 · Cited by 31
Analysis of Aeruginascin in Fruit Bodies of the Mushroom Inocybe aeruginascens
Gartz, J. (1989) · International Journal of Crude Drug Research · doi:10.3109/13880208909053954 · Cited by 27
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Taylor, A. P., Mortari, M. R., & Caldas, E. D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00854-w · Cited by 23
Shibaguchi, H., Takemura, K., Kan, S., Kataoka, Y., Kaibara, M., Saito, N., & Taniyama, K. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007022428041 · Cited by 16
Zandonadi, F. D. S., Silva, A., Melo, A. A. S., Ignarro, R. S., Matos, T. S., dos Santos, E. A. F., Barbosa, L. D., de Oliveira, A. L. R., Porcari, A. M., & Sussulini, A. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04556-3 · Cited by 12 · cited 1×
“A recent study analyzed the effects of ayahuasca treatments on primary astrocytes, revealing alterations in various biochemical pathways [33].”
5-HT2CR Is as Important as 5-HT2AR in Inducing Hallucinogenic Effects in Serotonergic CompoundsPreprint
Custodio, R. J. P., Ortiz, D. M., Lee, H. J., Sayson, L. V., Buctot, D. B., Kim, M., Lee, Y. S., Kim, K., Cheong, J. H., & Kim, H. J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4121838 · Cited by 5 · cited 1×
“We found that PSIL and PME signi fi cantly increased GAP43 levels in the frontal cortex (PSIL p = 0.019; PME p = 0.039) and hippocampus (PSIL p = 0.015; PME p = 0.027) and synaptophysin levels in the hippocampus (PSIL, p = 0.041; PME, p = 0.05) and amygdala (PSIL, p = 0.035; PME, p = 0.004).”
InfluentialSugishita, T., Tokunaga, M., Kami, K., Terai, K., Yamamoto, H., Shinohara, H., & Kinugasa, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11061706 · Cited by 5
Ignjatović, Đ., Tovilović-Kovačević, G., Mićić, B., Tomić, M., Djordjevic, A. D., Μacut, D., & Milutinović, D. V. (2023) · Hormones and Behavior · doi:10.1016/j.yhbeh.2023.105392 · Cited by 4
Cited by
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., Perugi, G., & Marazziti, D. (2025) · Brain Sciences · doi:10.3390/brainsci15020117 · Cited by 74
“A WB study in mice showed an increased expression of molecular biomarkers of synaptic plasticity (SV2A, GAP43, synaptophysin) 11 days after the administration of both synthetic psilocybin and mushroom extract in various brain areas including the prefrontal cortex, hippocampus and amygdala [65].”
Li, G., Wu, Q., Wang, C., Deng, P., Li, J., Zhai, Z., & Li, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-82571-9 · Cited by 40
Brownstien, M., Lazar, M., Botvinnik, A., Shevakh, C., Blakolmer, K., Lerer, L., Lifschytz, T., & Lerer, B. (2025) · Molecular Psychiatry · doi:10.1038/s41380-024-02786-0 · Cited by 30
Self-citationPsilocybin for the treatment of Alzheimer’s disease
Zheng, S., Ma, R., Yang, Y., & Li, G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420601 · Cited by 28
“Psychedelic mushroom extract significantly increased GAP43, PSD95, synaptophysin, and SV2A across all brain areas, while psilocybin effects were limited to PSD95 and SV2A in the hippocampus and amygdala (Shahar et al., 2024).”
BackgroundWerle, I., & Bertoglio, L. J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105899 · Cited by 26
Metadata
- Authors
- Shahar, O., Botvinnik, A., Shwartz, A., Lerer, E., Golding, P., Buko, A., Hamid, E., Kahn, D., Guralnick, M., Blakolmer, K., Wolf, G., Lotan, A., Lerer, L., Lerer, B., & Lifschytz, T.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Israel Institute for Biological Research (IL)
- Corresponding author
- Lerer, Bernard
- Lifschytz, Tzuri
- Venue
- Molecular Psychiatry
- Published
- 2024-02-20
- Volume
- 29
- Issue
- 7
- Pages
- 2059-2073
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC11408259
- OpenAlex
- W4391970820
- Cited by
- 40
- References
- 80
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 8
- FWCI
- 19.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Back of the Yards algae sciences (BYAS) and Parow Entheobiosiences
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- psilocybin, tryptamine alkaloids, head-twitch response, synaptic plasticity, synaptic proteins, GAP-43, PSD-95, synaptophysin, SV2A, purine metabolism, purine nucleotides, neuroplasticity, mouse brain, hippocampus, amygdala
- MeSH terms
- Agaricales, Animals, Brain, Frontal Lobe, Hallucinogens, Male, Mice, Inbred C57BL, Neuronal Plasticity, Psilocybin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.